Aiforia releases a new CE-IVD marked AI solution for gastric cancer diagnostics
recent articles
Indica Labs: Learn about the latest advancements in AI-powered pathology CRC Macrodissect AI and Breast HER2 AI Sneak Peek Date: 27 March 2025 Time: 8:00 – 9:00 PDT | 11:00 – 12:00 EDT | 15:00 – 16:00...
Aidoc: Building on Aidoc’s CARE™ Foundation Model, collaboration to tackle systemic care delivery challenges and shape the future of AI-driven health systems. Aidoc, the global leader in clinical AI, today announced a strategic...
Mark Clymer of Accu-Scope sat down for an interview with Hari Subramanian from ASP Healthcare. They explored the challenges of the current ROSE process and provide one avenue of solutions that increase consistency and throughput, and...
Join Leica Biosystems and NEO Genomics for next week's webinar. Optimization of IHC & digital pathology workflows in the development of novel therapeutic ADCs Date: March 5, 2025 Time: 8:00 AM (PT), 11:00 AM (ET) REGISTER...
From Pathology News: Analyzing the genetic content of cancer is an important step for accurate prognostication and treatment of affected patients. Tumor genetic testing is becoming increasingly more commonplace as the number of...
SALT LAKE CITY, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, and PATHOMIQ, Inc., a developer of artificial intelligence (AI)-enabled prognostic and...
